Venclexta Phase News Today

AbbVie Inc. (NYSE:ABBV) Q4 2023 Earnings Call Transcript February 2, 2024 AbbVie Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and thank you for standing by. Welcome to the AbbVie Fourth Quarter 2023 Earnings Conference Call. All […]